COR vs MET · P/E 21, rev $321.33B vs P/E 13, $52.16B cap
Cencora Inc. (COR) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
MET does not have a complete income-statement cache yet.
COR currently screens at market cap $53.91B and trailing P/E 21.2. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the COR and MET stock pages for the full models.
Not investment advice.